Senokot 7.5mg tablets 12 Years Plus

País: Regne Unit

Idioma: anglès

Font: MHRA (Medicines & Healthcare Products Regulatory Agency)

ingredients actius:

Senna fruit

Disponible des:

Reckitt Benckiser Healthcare (UK) Ltd

Codi ATC:

A06AB06

Designació comuna internacional (DCI):

Senna fruit

Dosis:

7.5mg

formulario farmacéutico:

Oral tablet

Vía de administración:

Oral

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 01060200; GTIN: 5011417579008 5011417579022 5011417580936

Informació per a l'usuari

CUSTOMER INFO:
Minimum Point Size =
9.00pt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BARCODE INFO
Barcode Type:
Barcode Number:
Magnification:
Truncated By:
Full Height:
Bar Height (Smallest Bar):
BWR:
Encoded Data:
Trident Reference No:
ZEN Ref:
Action:
Brand:
Category:
Segment Group:
Segment:
Pack Size:
Market/Country:
Date:
Component Code
(2D if applicable)
:
2
nd
Component Code
(if applicable)
:
Parent Technical Packaging Specification:
Finished Goods Code:
Supply Point:
3rd Party Code
Pharmacode No/NE:
Edgemark Position:
CAD Cam Ref:
Printer:
Substrate:
N/A
N/A
RB Hull
N/A
0000000
Senokot
Stimulant Laxative
Senna
Regular Tablet
100Tablets
RB482735
Please note that any low resolution paper Canon colour copies
associated with this job should be referred to for content, layout
and colour separation only.
STUDIO USE ONLY
v2.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
Cutter 2 (if applicable)
Guides 2 (if applicable)
Multi Packaging Solutions (Tewkesbury, UK)
Skt-Lft-D8372157-160mmx250mm
TR2244996
Paper White
UK
23/07/21
A
Senthamil Tamilmani
0000000
N/A
G=2; O=0; R=0; - ST - 23/07/21 10:55:40
RB Artwork and
Print Specification
D8372157
Artwork Type:
BW Submission
10
mm
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
1
LTH
PANTONE 347 C
Colours (Leaflet)
RBH Contact:
Alexander Titmus
Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T: [phone]
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
PACKAGE LEAFLET: INFORMATION FOR THE USER
SENOKOT 7.5MG TABLETS 12 YEARS PLUS
SENNA FRUIT (PODS)
READ THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist have told you.
•
ASK YOUR PHARMACIST IF YOU NEED MORE INFORMATION OR ADVICE.
•
If any of the side effects get serious or if you notice any side
effect not

Fitxa tècnica

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Senokot 7.5 mg Tablets 12 Years Plus
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains powdered Alexandrian Senna fruit (pods) (_Cassia
senna _
L._ _(_C. acutifolia _Delile)) and Tinnevelly Senna fruit (pods)
(_Cassia _
_angustifolia _Vahl) equivalent to 7.5mg hydroxyanthracene glycosides,
calculated as sennoside B.
Each tablet also contains 15.82 mg lactose monohydrate
For full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablets
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the short-term relief of occasional constipation
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral administration.
The correct individual dose is the smallest required to produce a
comfortable
soft-formed motion.
Adults, the elderly and children over 12 years: Swallow one to two
tablets at
night
Should not be used in children or adolescents under the age of 12
years (see
section 4.3).
New users should start with the lowest dose and increase it to the
maximum
dose if necessary. Once regularity has been regained dosage should be
reduced
and can usually be stopped.
If no bowel action has occurred after three days of progressively
increased
dosage, a medical examination should be considered.
Duration of use
Not to be used for more than 1 week. Usually it is sufficient to take
this
medicinal product up to two to three times during that week.
If the symptoms persist during the use of the medicinal product, a
doctor or a
pharmacist should be consulted.
See also section 4.4 Special warnings and precautions for use.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
Not to be used at the same time as other laxative agents.
Cases of intestinal obstructions and stenosis, atony, appendicitis,
inflammatory
bowel diseases (e.g Crohn’s disease, ulcerative colitis), abdominal
pain of
unknown origin, severe dehydration state with water and electrolyte
depletion
Children under 12 years of age.
4.4
SPECIAL WARNINGS